Privia health group, inc.PRVA.US Overview
PRVA Overall Performance
PRVA AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
PRVA Key Information
PRVA Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
PRVA Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
PRVA Profile
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Price of PRVA
PRVA FAQ
When is PRVA's latest earnings report released?
The most recent financial report for Privia health group, inc. (PRVA) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PRVA's short-term business performance and financial health. For the latest updates on PRVA's earnings releases, visit this page regularly.
Where does PRVA fall in the P/E River chart?
According to historical valuation range analysis, Privia health group, inc. (PRVA)'s current price-to-earnings (P/E) ratio is 162.36, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of PRVA?
According to the latest financial report, Privia health group, inc. (PRVA) reported an Operating Profit of 14.4M with an Operating Margin of 2.48% this period, representing a growth of 147.77% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is PRVA's revenue growth?
In the latest financial report, Privia health group, inc. (PRVA) announced revenue of 580.42M, with a Year-Over-Year growth rate of 32.54%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does PRVA have?
As of the end of the reporting period, Privia health group, inc. (PRVA) had total debt of 6.24M, with a debt ratio of 0. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does PRVA have?
At the end of the period, Privia health group, inc. (PRVA) held Total Cash and Cash Equivalents of 441.35M, accounting for 0.33 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does PRVA go with three margins increasing?
In the latest report, Privia health group, inc. (PRVA) achieved the “three margins increasing” benchmark, with a gross margin of 11%%, operating margin of 2.48%%, and net margin of 1.2%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PRVA's profit trajectory and future growth potential.
Is PRVA's EPS continuing to grow?
According to the past four quarterly reports, Privia health group, inc. (PRVA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.06. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of PRVA?
Privia health group, inc. (PRVA)'s Free Cash Flow (FCF) for the period is 51.99M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 56.83% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of PRVA?
The latest valuation data shows Privia health group, inc. (PRVA) has a Price-To-Earnings (PE) ratio of 162.36 and a Price/Earnings-To-Growth (PEG) ratio of 0.64. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.